期 |
栏目 |
标题 |
文件 |
卷 21, 编号 2 (2018) |
ORIGINAL ARTICLES |
A STUDY ON THE ASSOCIATION OF IL‑1RAVNTR AND IL‑1α (С+889T) GENE POLYMORPHISMS WITH FEATURES OF ESSENTIAL HYPERTENSION |
(Rus)
|
卷 22, 编号 2-2 (2019) |
ORIGINAL ARTICLES |
GENERATION AND CHARACTERIZATION OF RECOMBINANT ANTIBODY AGAINST THE COMPLEMENT C5a ANAPHYLATOXIN |
(Rus)
|
卷 22, 编号 2-2 (2019) |
ORIGINAL ARTICLES |
COMPLEMENT IN PATHOLOGIES, POSSIBILITY OF CORRECTION USING A NOVEL HUMANIZED ANTIBODY THAT CAN BLOCK ALTERNATIVE PATHWAY OF COMPLEMENT SYSTEM ACTIVATION |
(Rus)
|
卷 22, 编号 3 (2019) |
ORIGINAL ARTICLES |
MONOCLONAL ANTIBODY TO HUMAN PD-1 END DETERMINATION OF ITS SPECIFIC ACTIVITY BY FLOW CYTOMETRY |
(Rus)
|
卷 22, 编号 4 (2019) |
ORIGINAL ARTICLES |
DYNAMICS OF CYTOKINE LEVELS IN BLOOD SERUM IN PATIENTS WITH METABOLIC SYNDROME USING STATINS |
(Rus)
|
卷 22, 编号 2-2 (2019) |
ORIGINAL ARTICLES |
LEVELS OF PERIPHERAL BLOOD CYTOKINES AND THE RISK FOR METABOLIC SYNDROME IN PATIENTS WITH STAGE II ESSENTIAL HYPERTENSION |
(Rus)
|
卷 23, 编号 4 (2020) |
SHORT COMMUNICATIONS |
Serum macrophage colony-stimulating factor levels in patients with essential hypertension after SARS-CoV-2 infection |
(Rus)
|
卷 25, 编号 4 (2022) |
SHORT COMMUNICATIONS |
Cytokines of the IL-6 family, adiponectin and leptin levels in patients with metabolic syndrome during the post-COVID period |
(Rus)
|
卷 24, 编号 4 (2021) |
SHORT COMMUNICATIONS |
Serum macrophage colony-stimulating factor levels in patients with essential hypertension after vaccination against SARS-CoV-2 |
(Rus)
|
卷 25, 编号 3 (2022) |
SHORT COMMUNICATIONS |
Cytokine system in the patients with type 2 diabetes mellitus non-infected with SARS-CoV-2 |
(Rus)
|
卷 26, 编号 4 (2023) |
Forum Sochi 2023 |
Clinical and immunological efficacy of intranasal interferon in the post-vaccination period in patients vaccinated against SARS-CoV-2 coronavirus |
(Rus)
|